Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Other Operating Expenses: 2010-2025

Historic Other Operating Expenses for Lifecore Biomedical (LFCR) over the last 11 years, with May 2025 value amounting to $409,000.

  • Lifecore Biomedical's Other Operating Expenses rose 54.54% to -$1.1 million in Q2 2025 from the same period last year, while for May 2025 it was $409,000, marking a year-over-year decrease of 98.96%. This contributed to the annual value of $409,000 for FY2025, which is 98.96% down from last year.
  • According to the latest figures from FY2025, Lifecore Biomedical's Other Operating Expenses is $409,000, which was down 98.96% from $39.5 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Other Operating Expenses high stood at $39.5 million for FY2024, and its period low was -$2.1 million during FY2023.
  • Over the past 3 years, Lifecore Biomedical's median Other Operating Expenses value was $409,000 (recorded in 2025), while the average stood at $12.6 million.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first surged by 1,973.81% in 2024, then plummeted by 98.96% in 2025.
  • Yearly analysis of 3 years shows Lifecore Biomedical's Other Operating Expenses stood at -$2.1 million in 2023, then spiked by 1,973.81% to $39.5 million in 2024, then slumped by 98.96% to $409,000 in 2025.